Bufo Alvarious

---

Disclaimer: This guide is for educational and awareness purposes only. It is not medical advice, nor does it encourage use of any controlled substances. Always prioritize safety, legality, and personal responsibility.

Chemical formula: C₁₃H₁₈N₂O

Chemical name: 5-methoxy-N,N-dimethyltryptamine

This guide is intended to provide clear, responsible information for individuals who are considering taking this substance, with a focus on awareness and safety.

5-MeO-DMT is a naturally occurring psychedelic compound that can be found in certain plants and in the secretions of the Sonoran Desert toad, a species native to parts of northern Mexico and the southwestern United States.

Throughout human history, many cultures have explored altered states of consciousness through a variety of traditional practices and plant-based substances. In regions of Central and South America, psychoactive preparations made from plants such as yopo have been used in ritual and healing contexts for centuries.

In recent decades, the use of 5-MeO-DMT—particularly in vaporised form—has gained attention in modern psychedelic communities. It is sometimes presented as having connections to ancient practices, although evidence for the historical use of toad-derived 5-MeO-DMT specifically is limited and remains a subject of debate.

Experiences involving this substance are often described as intense and deeply immersive. Some individuals report profound psychological or emotional effects, including shifts in perception, personal insight, or a sense of detachment from ordinary awareness. For others, the experience can be overwhelming or challenging.

Because of its strength and unpredictability, 5-MeO-DMT is not considered a casual or recreational substance. Anyone choosing to engage with it should understand that outcomes vary widely, and that personal responsibility plays a central role in how the experience is approached and integrated afterward.

5-MeO-DMT (also called 5-methoxy-N,N-dimethyltryptamine, 5-MeO) is a potent psychedelic compound in the tryptamine family. It occurs naturally in several plant species and in the secretions of the Sonoran Desert toad. While structurally related to DMT, its effects are often described as more intense, brief, and transformative.

Because of its potency, even small variations in dosage, context, or individual sensitivity can produce dramatically different experiences. Extreme care, preparation, and awareness are critical for anyone seeking to learn about this substance.

Throughout history, humans have explored altered states of consciousness through ritual, spiritual practice, and plant-based preparations. In Central and South America, snuffs made from plants like yopo (Anadenanthera peregrina) and Virola species have been used in ceremonial settings for centuries.

The Sonoran Desert toad’s secretion, which contains 5-MeO-DMT, has been used in modern times, often framed as a continuation of these ancient traditions. While the broader cultural practices are well-documented, direct historical use of toad-derived 5-MeO-DMT remains less certain and continues to be a topic of scholarly discussion.

Modern interest in 5-MeO-DMT has grown in both psychedelic research communities and personal development circles, but its unpredictable nature means it should not be considered a casual or recreational substance.

Users often describe 5-MeO-DMT experiences as intense, immersive, and brief, typically lasting 20–30 minutes when inhaled. Effects may include:

• Profound shifts in perception and awareness 
• Altered sense of time, space, and self 
• Heightened physical sensations or emotional intensity 
• Feelings of unity, ego dissolution, or detachment from surroundings 
• Auditory changes, nausea, or temporary memory disruption during peak effects 

Every experience is unique, and responses are highly individual. Preparation, mindset, and a safe set and setting are crucial for minimizing risks.

5-MeO-DMT primarily interacts with serotonin receptors (notably 5-HT1A, with partial activity at 5-HT2A). Its effects are influenced by dosage, individual brain chemistry, and environmental factors. Caution is essential, particularly when combined with other substances such as MAOIs, which can dangerously amplify effects.

5-MeO-DMT carries significant physical and psychological risks. Key safety points include:

• Serotonin syndrome: Can occur when combined with substances that affect serotonin. 
• Physical risks: Changes in heart rate, blood pressure, or body temperature. 
• Environmental considerations: Collecting toad secretions may threaten local populations; synthetic alternatives are safer and more sustainable. 

Safe practices often involve a sober sitter, careful measurement, and avoidance of other substances. Begin with minimal exposure if learning about the compound, and never assume prior psychedelic experience guarantees safety.

Approximate ranges reported in research and anecdotal sources:

• Synthetic 5-MeO-DMT: 
  • Low: 3–6 mg 
  • Moderate: 6–10 mg 
  • High: 11–15 mg+ 
• Naturally derived: 
  • Low: 10–20 mg 
  • Moderate: 20–40 mg 
  • High: 40–60 mg+ 

These ranges are for awareness; individual sensitivity can vary dramatically.

5-MeO-DMT is a controlled substance in many countries. Possession, extraction, or distribution may carry severe legal penalties. Use of animal-derived sources raises ecological and ethical concerns. Respect for cultural practices and species conservation is essential.

Some individuals explore 5-MeO-DMT for personal insight or spiritual growth. Integration practices—such as reflection, journaling, movement, and therapy—can help translate experiences into meaningful outcomes. Even then, benefits are unpredictable, and professional guidance is recommended for anyone considering deeper work.

Laws vary depending on the country. 5-MeO-DMT is a controlled substance, meaning possession, supply, or importation may be illegal. Always check local laws before engaging with any substance.

Most standard drug tests do not screen for 5-MeO-DMT. It also typically does not trigger false positives. However, this does not guarantee it cannot be detected under specialised testing conditions.

Risks include intense psychological reactions, loss of coordination, breathing irregularities, and potential medical complications. The risk increases significantly when combined with other substances, especially antidepressants or MAOIs.

Yes. Some individuals report ongoing anxiety, confusion, or emotional sensitivity after the experience. While severe long-term effects appear uncommon, they are possible, especially without proper preparation and integration.

Inhalation is the most commonly reported due to its short duration, but it still carries risks. Other methods may increase unpredictability and intensity.

No. Mixing with alcohol, antidepressants, or other psychoactive substances can significantly increase risks, including dangerous physiological reactions and loss of control.

There is no established safe microdosing range. Effects can vary widely, and even small amounts may produce strong reactions in some individuals.

When inhaled, effects typically begin within seconds, peak within minutes, and resolve within 20–30 minutes. However, psychological effects may linger longer.

No. While chemically related, 5-MeO-DMT and DMT produce different experiences. 5-MeO-DMT is often described as less visual but more intense in terms of psychological and perceptual impact.

There are growing environmental and ethical concerns. Harvesting from toads can harm populations and ecosystems. Many consider synthetic alternatives a more sustainable option.

Risk can be reduced by:

• avoiding substance combinations 
• ensuring a safe environment 
• having a sober, trusted person present 
• starting with minimal exposure 
• prioritising preparation and integration 
• choosing experienced facilitators/sitter

                                                            References 

Shulgin, A., Shulgin, A. (1997). TiHKAL: The Continuation. U.S.: Transform Press. Retrieved from: https://amzn.to/2CKnBlp.

PsychonautWiki. 5-MeO-DMT. Retrieved from: https://psychonautwiki.org/wiki/5-MeO-DMT.

Vegan. (2006). Otherworldly Bliss: An Experience with 5-MeO-DMT (ID 523111). Erowid. Retrieved from: https://erowid.org/experiences/exp.php?ID=52311.

Netrunner. (2014). The Power and The Glory: An Experience with Harmaline, 5-MeO-DMT & DMT (ID 34866). Erowid. Retrieved from: https://erowid.org/experiences/exp.php?ID=34866.

Earth Erowid. (2015). Ayahuasca Conference. Retrieved from: https://erowid.org/general/conferences/conference_ayahuasca1.shtml.

Bowers, J. (2015). Personal Story: My 5-MeO-DMT Experience. Reset.me. Retrieved from: https://reset.me/personal-story/personal-story-my-5-meo-dmt-experience/.

Shen, H., Jiang, X., Winter, J. C., Yu, A. (2010). Psychedelic 5-Methoxy-N,N-dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions. Current Drug Metabolism, 11(8), 659-666. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028383/pdf/nihms-264719.pdf.

Wallach, J. V. (2009). Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception. Medical Hypotheses, 72(1), 91-4. Retrieved from: https://www.sciencedirect.com/science/article/abs/pii/S0306987708003988?via%3Dihub.

Yu, A. (2008). Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions. The AAPS Journal, 10(2), 242. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751378/pdf/12248_2008_Article_9028.pdf.

Brush, D. E., Bird, S. B., Boyer, E. W. (2004). Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. Journal of Toxicology: Clinical Toxicology, 42(2), 191-5. Retrieved from: https://www.researchgate.net/publication/8492869_Monoamine_Oxidase_Inhibitor_Poisoning_Resulting_from_Internet_Misinformation_on_Illicit_Substances.

Sklerov, J., Levine, B., Moore, K. A., King, T., Fowler, D. (2005). A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. Journal of Analytical Toxicology, 29(8), 838-41. Retrieved from: https://academic.oup.com/jat/article/29/8/838/716730.

Tittarelli, R., Mannocchi, G., Pantano, F., Romolo, F. S. (2015). Recreational Use, Analysis and Toxicity of Tryptamines. Current Neuropharmacology, 13(1), 26-46. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462041/pdf/CN-13-26.pdf.

Oram, R. N., Edlington, J. P. (1996). Breeding Non-Toxic Phalaris (Phalaris Aquatica L.). The Regional Institute. Retrieved from: http://agronomyaustraliaproceedings.org/images/sampledata/1996/contributed/450oram.pdf.

Erowid. (2015). 5-MeO-DMT (5-Methoxydimethyltryptamine) Health. Retrieved from: https://erowid.org/chemicals/5meo_dmt/5meo_dmt_health.shtml.

Psychedelic Times Staff. (2016). Exploring the Sacred Power of 5-MeO-DMT and the Psychedelic Toad: Podcast with Dr. Gerardo Sandoval. Psychedelic Times. Retrieved from: https://psychedelictimes.com/dmt-podcast-with-dr-gerardo-sandoval/.

Roger R. (2016). What is the Difference between 5-MeO-DMT and DMT? Choosing a DMT Therapy. Psychedelic Times. Retrieved from: https://psychedelictimes.com/what-is-the-difference-between-5-meo-dmt-and-dmt-choosing-a-dmt-therapy/.

Wes T. (2015). At the Crossroads of Ibogaine and 5-MeO-DMT: An Interview with Dr. Martin Polanco. Psychedelic Times. Retrieved from: https://psychedelictimes.com/at-the-crossroads-of-ibogaine-and-5-meo-dmt-interview-with-dr-martin-polanco/.

Bateman, D. N., Jefferson, R. D., Thomas, S., Thompson, J. P., Vale, A. (2014). Oxford Desk Reference: Toxicology. Oxford University Press. Retrieved from: https://amzn.to/3i28jIR.

Archer, T., Minor, B. G., Post, C. (1985). Blockade and Reversal of 5-Methoxy-N,N-Dimethyltryptamine-Induced Analgesia Following Noradrenaline Depletion. Brain Research, 333, 55-61. Retrieved from: https://www.sciencedirect.com/science/article/abs/pii/0006899385901234?via%3Dihub.

Dakic, V. et al. (2017). Short term changes in the proteome of human cerebral organoids induced by 5-methoxy-N,N-dimethyltryptamine. bioRxiv preprint. Retrieved from: https://www.biorxiv.org/content/10.1101/108159v1.full.pdf.

Frontiers in. Research Topic: Psychotropic Substances and the Immune System: Implications in Allergy, Autoimmunity, Cancer, and Neuropsychiatric Disorders. Retrieved from: https://www.frontiersin.org/research-topics/5163/psychotropic-substances-and-the-immune-system-implications-in-allergy-autoimmunity-cancer-and-neurop.

Archer, T. et al. (1987). (+)-8-OH-DPAT and 5-MeODMT Induced Analgesia is Antagonised by Noradrenaline Depletion. Physiology & Behavior, 39, 95-102. Retrieved from: https://www.sciencedirect.com/science/article/abs/pii/0031938487903507?via%3Dihub.

Q4LT. (2016). Placebo Effect. Retrieved from: https://www.dmtquest.org/blog/placebo-effect.

Szabo, A., Kovacs, A. Frecska, E., Rajnavolgyi, E. (2014). Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells. PLOS ONE. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149582/pdf/pone.0106533.pdf.

 Dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J, Zuardi, A. W., Hallak, J. E. C. (2016). Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology, 6(3), 193-213. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910400/pdf/10.1177_2045125316638008.pdf.

Lola B. Prime, Probe, Process: An Experience with 5-MeO-DMT (ID 56384). Erowid. Retrieved from: https://erowid.org/experiences/exp.php?ID=56384.

Wes T. (2016). Psychedelic Research with Ibogaine and 5-MeO-DMT: An Interview with Dr. Joseph Barsuglia. Psychedelic Times. Retrieved from: https://psychedelictimes.com/psychedelic-research-with-ibogaine-and-5-meo-dmt-an-interview-with-dr-joseph-barsuglia/.

Riga, M. S., Soria, G., Tudela, R., Artigas, F., Celada, P. (2014). The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs. International Journal of Neuropsychopharmacology, 17(8), 1269-1282. Retrieved from: https://academic.oup.com/ijnp/article/17/8/1269/661800.

Szabo, A. (2015). Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities. Frontiers in Immunology, 6, 358. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500993/pdf/fimmu-06-00358.pdf.

Tryptamine Palace. Smoking 5-MeO-DMT; Ceremony, Method and Dosage. Retrieved from: https://amzn.to/3i53Zso.

Torres, C. M., Repke, D. B. (2014). Anadenanthera: Visionary Plant of Ancient South America. Routledge. Retrieved from: https://amzn.to/3g5aOsd.

AP. (2019, Jun 5). The Latest: Oakland 2nd US city to legalize magic mushrooms. Retrieved from https://www.apnews.com/ff023dfbf4534eba8622f504d272ff00.

Decriminalize Nature Oakland. Resolution. Retrieved from https://www.decriminalizenature.org/dno-resolution.

Canada Justice Laws Website. (2019, May 15). Controlled Drugs and Substances Act (S.C. 1996, c. 19). Retrieved from https://laws-lois.justice.gc.ca/eng/acts/C-38.8/.

Erowid. (2015). 5-MeO-DMT Legal Status. Retrieved from: https://erowid.org/chemicals/5meo_dmt/5meo_dmt_law.shtml.

Erowid. (2015). 5-MeO-DMT Timeline. Retrieved from: https://www.erowid.org/chemicals/5meo_dmt/5meo_dmt_timeline.php.

Pané, R. (1999). An Account of the Antiquities of the Indians. Juan Arrom, J. (Ed.). Duke University Press. Retrieved from: https://amzn.to/31nlFth.

Tryptamine Palace. Traditional Use. Retrieved from: https://amzn.to/3g1CUV7.

Von Humboldt, A. (1907). Personal Narrative of Travels to the Equinoctial Regions of America, During the Years 1799-1804. London: George Bell & Sons. Retrieved from: https://amzn.to/2Yx8LXU.

Hoshino, T., Shimodaira, K. (1936). ÜBER DIE SYNTHESE DES BUFOTENIN-METHYL-ÄTHERS (5-METHOXY-N-DIMETHYL-TRYPTAMIN) UND BUFOTENINS (SYNTHESEN IN DER INDOL-GRUPPE. XV). Bulletin of the Chemical Society of Japan, 11(3), 221-224. Retrieved from: https://www.journal.csj.jp/doi/pdf/10.1246/bcsj.11.221.

Beckley Foundation. DMT. Retrieved from: https://beckleyfoundation.org/ayahuascadmt/.

The Sonoran Desert Toad. Erowid. Retrieved from: https://www.erowid.org/archive/sonoran_desert_toad/deeptoad.htm.

Stuart, R. Entheogenic Sects and Psychedelic Religions. MAPS. Retrieved from: https://maps.org/news-letters/v12n1/12117stu.html.

Most, A. (1983). Bufo alvarius: The Psychedelic Toad of the Sonoran Desert. Erowid. Retrieved from: https://erowid.org/archive/sonoran_desert_toad/almost.htm.

Turner, D. M. (1994). The Essential Psychedelic Guide. San Francisco, CA: Panther Press. Retrieved from: https://amzn.to/3i0SxOq.

Dunn, T. (2002). The Strange Case of Mark Niemoeller. AlterNet. Retrieved from: https://www.alternet.org/2002/02/the_strange_case_of_mark_niemoeller/.

Erowid Crew. (2009). 5-MeO-DMT is Not “DMT”: Differentiation is Wise. Erowid Extracts, 17, 16. Retrieved from: https://erowid.org/chemicals/5meo_dmt/5meo_dmt_article1.shtml.

Oroc, J. (2009). Tryptamine Palace: 5-MeO-DMT and the Sonoran Desert Toad. Inner Traditions / Bear & Co. Retrieved from: https://amzn.to/3dvzto0.

Weil, A. T., Davis, W. (1994). Bufo alvarius: a potent hallucinogen of animal origin. Journal of Ethnopharmacology, 41, 1-8. Retrieved from: https://www.sciencedirect.com/science/article/abs/pii/0378874194900515?via%3Dihub.

Erowid. (2015, Feb 10). 5-MeO-DMT Basics. Retrieved from https://erowid.org/chemicals/5meo_dmt/5meo_dmt_basics.shtml

5-MeO-DMT Concerns [Forum thread]. Retrieved from https://www.dmt-nexus.me/forum/default.aspx?g=posts&t=66540

Serious question on the psychological effects of 5-MEO-DMT and N,N-DMT [Forum thread]. Retrieved from http://www.bluelight.org/vb/threads/512537-Serious-question-on-the-psychological-effects-of-5-MEO-DMT-and-N-N-DMT

A.S., CA. (2009, Jun 8). 5-MeO-DMT Warning: An Experience with 5-MeO-DMT (exp78870). Retrieved from https://www.erowid.org/experiences/exp.php?ID=78870.

Astral-blood. 5-MEO-DMT Safety (Recent Death) [Forum thread]. Thread posted to https://www.reddit.com/r/DMT/comments/6bxuhq/5meodmt_safety_recent_death/.

Shulgin, A., Shulgin, A. (2015, Feb 21). Erowid Online Books : “TIHKAL” – #38 5-MEO-DMT. Retrieved from https://erowid.org/library/books_online/tihkal/tihkal38.shtml.

Erowid. (2015, Feb 21). 5-MeO-MIPT Dosage. Retrieved from https://www.erowid.org/chemicals/5meo_mipt/5meo_mipt_dose.shtml.

PsychonautWiki. 5-MeO-MiPT. Retrieved from https://psychonautwiki.org/wiki/5-MeO-MiPT.

CiaraFan79. Why is 5-MeO-MiPT so unique? [Forum thread]. Thread posted to https://www.reddit.com/r/researchchemicals/comments/675lh2/why_is_5meomipt_so_unique/.

Erowid. (2015, Feb 21). 5-MeO-DiPT Dosage. Retrieved from https://www.erowid.org/chemicals/5meo_dipt/5meo_dipt_dose.shtml.

PsychonautWiki. 5-MeO-DiPT. Retrieved from https://psychonautwiki.org/wiki/5-MeO-DiPT.

Erowid. (2015, Nov 26). 5-MeO-DiPT – Legal Status. Retrieved from https://www.erowid.org/chemicals/5meo_dipt/5meo_dipt_law.shtml.

TripSit Factsheets – 5-MeO-MALT. Retrieved from http://drugs.tripsit.me/5-meo-malt.

Triple7. (2004, Dec 23). 5-MeO-DET trip reports. Retrieved from https://drugs-forum.com/threads/5-meo-det-trip-reports.4109/.

 Erowid. (2015, Feb 10). 5-MeO-DALT – Dose. Retrieved from https://www.erowid.org/chemicals/5meo_dalt/5meo_dalt_dose.shtml.

PsychonautWiki. 5-MeO-DALT. Retrieved from https://psychonautwiki.org/wiki/5-MeO-DALT.

Lower Colorado River Multi-Species Conservation Program

StuckMojo. (20014, Jun 26). The Big & Dandy 5-MeO-DALT Thread [Forum thread]. Thread posted to https://www.bluelight.org/xf/threads/the-big-dandy-5-meo-dalt-thread.146249/page-2.

Ditrapano, G. (2016, Nov 19). How Psychedelics Helped Me Deal with Excruciating Cluster Headaches. Retrieved from https://www.vice.com/en_uk/article/5gqymd/how-psychedelics-helped-me-deal-with-excruciating-cluster-headaches.

Shulgin, A., Shulgin, A. (2015, Feb 21). Erowid Online Books : “TIHKAL” – #36. 5-MEO-DET. Retrieved from https://www.erowid.org/library/books_online/tihkal/tihkal36.shtml.

Shulgin, A., Shulgin, A. (2015, Feb 21). Erowid Online Books : “TIHKAL” – #43 5-MEO-PYR-T. Retrieved from https://erowid.org/library/books_online/tihkal/tihkal43.shtml.

Shulgin, A., Shulgin, A. (2015, Feb 21). Erowid Online Books : “TIHKAL” – #45 5-MEO-TMT. Retrieved from https://www.erowid.org/library/books_online/tihkal/tihkal45.shtml.

Online Sunshine. The 2018 Florida Statutes – Title XLVI, Chapter 893. Retrieved from http://leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/0893.html.

Erowid. (2015, Feb 21). 5-MeO-AMT Dosage. Retrieved from https://www.erowid.org/chemicals/5meo_amt/5meo_amt_dose.shtml.

Erowid. (2015, Feb 10). 5-MeO-AMT Hospitalizations & Possible Deaths Jan 2007, V 1.2. Retrieved from https://www.erowid.org/chemicals/5meo_amt/5meo_amt_info1.shtml.

Erowid. (2015, Feb 10). 5-MeO-AMT – Legal Status. Retrieved from https://www.erowid.org/chemicals/5meo_amt/5meo_amt_law.shtml.